BridgeBio Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

XTRA:2CL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
09 Jul 26	Sell€81,773,022	Viking Global Investors LP	Company	1,282,822	€79.08
23 Feb 26	Sell€68,892,443	Viking Global Investors LP	Company	1,183,933	€64.80
13 Feb 26	Sell€90,435,394	Viking Global Investors LP	Company	1,367,567	€71.57
18 Nov 25	Sell€5,458,924	Wen-Chaun Lo	Individual	95,599	€57.92
15 Oct 25	Sell€17,029,980	Viking Global Investors LP	Company	374,915	€49.11

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2CL?
Owner Type	Number of Shares	Ownership Percentage
State or Government	72,010	0.0362%
Individual Insiders	7,697,580	3.87%
Hedge Funds	20,535,282	10.3%
Institutions	170,789,127	85.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.22%	Janus Henderson Group Ltd.	14,110,278	€885.0m	7.07%	0.34%
5.5%	Farallon Capital Management, L.L.C.	10,743,063	€673.8m	14.7%	4.68%
5.26%	BlackRock, Inc.	10,287,156	€645.2m	-27.6%	0.01%
5.01%	Viking Global Investors LP	9,792,219	€614.1m	-1.58%	2.0%
4.61%	Vanguard Capital Management, LLC	9,015,962	€565.5m	0.91%	0.01%
4.23%	KKR & Co. Inc.	8,260,971	€518.1m	-37.7%	5.8%
3.92%	Vanguard Portfolio Management, LLC	7,656,722	€480.2m	-5.25%	0.02%
2.72%	Wellington Management Group LLP	5,308,924	€333.0m	114%	0.06%
2.59%	Neil Kumar	5,067,460	€317.8m	-0.2%	no data
2.42%	Two Sigma Investments, LP	4,722,185	€296.2m	51.3%	0.27%
2.35%	Aisling Capital Management LP	4,589,611	€287.8m	-9.82%	76.13%
2.27%	State Street Investment Management	4,435,932	€278.2m	-10.1%	0.01%
1.92%	Citadel Advisors LLC	3,760,028	€235.8m	18.5%	0.16%
1.86%	D. E. Shaw & Co., L.P.	3,633,007	€227.9m	42.7%	0.18%
1.8%	Invesco Ltd.	3,519,443	€220.7m	-20.7%	0.06%
1.75%	Geode Capital Management, LLC	3,418,419	€214.4m	-30.5%	0.01%
1.5%	Jane Street Group, LLC	2,934,193	€184.0m	66.9%	0.12%
1.15%	Adage Capital Management, L.P.	2,252,000	€141.2m	276%	0.22%
1.14%	UBS Asset Management AG	2,236,910	€140.3m	-7.94%	0.01%
1.1%	Franklin Templeton Inc.	2,159,874	€135.5m	22.2%	0.04%
1.06%	Polar Capital Holdings Plc	2,063,609	€129.4m	-18.1%	0.31%
1.05%	FMR LLC	2,054,280	€128.8m	-12.1%	0.01%
1.05%	JP Morgan Asset Management	2,043,840	€128.2m	69.8%	0.01%
1%	Manulife Asset Management	1,955,733	€122.7m	-1.08%	0.09%
0.95%	Sequoia Capital Operations LLC	1,860,364	€116.7m	0%	0.33%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/15 04:49
End of Day Share Price	2026/09/15 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BridgeBio Pharma, Inc. is covered by 37 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eliana Merle	Barclays
"Eliana Merle	Barclays
Jason Zemansky	BofA Global Research